• Decrease font size
  • Default font           size
  • Increase font size
NPL To Use Accentus C3 Ultrasonic Technology For Research into Cavitation Monitoring Techniques PDF Print E-mail
Tuesday, 19 December 2006 12:46
The National Physical Laboratory (NPL, Teddington UK), the UK’s national standards laboratory, and Accentus, (Harwell UK) are pleased to announce that NPL are applying the Accentus patented C3 power ultrasonic reactor technology as part of a research programme whose objective is to investigate methods of characterising cavitation activity with high power applications.
 

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai